4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zhongzhi Pharmaceutical Holdings Limited (3737) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Zhongshan, China with about 2,284 employees. Its market capitalization is roughly CNY 578 million.
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | — | CNY 2.2B | CNY 2.0B | CNY 1.8B | CNY 1.7B |
| Gross Profit | — | CNY 1.3B | CNY 1.2B | CNY 1.1B | CNY 1.1B |
| Operating Income (EBIT) | — | CNY 156M | CNY 199M | CNY 129M | CNY 102M |
| Net Income | — | CNY 95M | CNY 163M | CNY 106M | CNY 52M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Dividends Paid | (CNY 23M) | (CNY 116M) | (CNY 0M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Assets | CNY 2.0B | CNY 1.8B | CNY 1.9B | CNY 1.5B |
| Total Liabilities | CNY 866M | CNY 739M | CNY 869M | CNY 623M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3737 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms